Shaping the future together in 2025

As we step into 2025, we want to take a moment to thank everyone who has been part of our journey in 2024.

To our team members, partners, and customers: your commitment and collaboration continue to drive innovation and positive influence on public health.

News

bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance

bioMérieux, a world leader in the field of in vitro diagnostics, announces the U.S. Food and Drug Administration (FDA) 510(k) clearance for VITEK® COMPACT PRO. This innovative system for microorganism identification (ID) and antibiotic susceptibility testing (AST) will benefit clinical laboratories to help diagnose infectious diseases and combat antimicrobial resistance, and industrial laboratories to identify contaminants for ensuring consumer safety.

Discover more

Swipe to discover more

bioMérieux – 2024 Financial Results

Consolidated sales amounted to €3,980 million in 2024, up 10.3% like-for-like from €3,675 million in the prior year period. Reported growth stood at +8.3% for the period.

Read the press release
Lab Innovations Empower Clinicians in the Fight Against Antimicrobial Resistance

In recent years, antimicrobial resistance (AMR) has sprung to the forefront of many medical and political conversations, with the warning that the prevalence of resistant pathogens could lead to a public health crisis. Ranked a top 10 global public health threat by the World Health Organization, it is estimated that 1.27 million deaths occurred in a single year attributable to AMR.

Read the blog post
bioMérieux and Vall d'Hebron Join Forces Against Infectious Diseases

bioMérieux announces a new strategic research partnership with Vall d'Hebron, one of Spain's largest and most prestigious healthcare institutions. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.

Read the news

Enabling Decision-Making

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

As an antimicrobial steward

BE A GAME CHANGER

You can help sustain antibiotic efficacy for future generations with the right diagnostic tests to guide appropriate antibiotic therapy.

Discover More

In the fight against sepsis

BE A GAME CHANGER

Time is of the essence with suspected sepsis. To make rapid & accurate decisions, diagnostic is a real support. bioMérieux commits to offer a complete solution for sepsis management – from antibiotic initiation, to monitoring, to appropriate discontinuation.

Discover more

As a protector of consumer health

BE A GAME CHANGER

When you select a diagnostic partner you can trust, manufacturing safe food and beverages comes with confidence.

Discover more

In ensuring quality pharmaceutical goods

BE A GAME CHANGER

By choosing the right partner and diagnostics solutions you can manufacture safer products, giving you confidence in the quality of your offer.

Discover more

In respiratory infections, including COVID-19

BE A GAME CHANGER

To make sure your patients don’t miss a breath, you need a partner you can count on. bioMérieux offers a comprehensive range of diagnostic tools enabling various RESPIRATORY linked infections, including primary diagnosis of SARS-CoV-2 you can rely on.

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

Hospital & Laboratory
Point of Care
Food Safety & Quality
Pharma Quality Control

VITEK^® REVEAL™

The newest addition to our Sepsis Solution, VITEK^® REVEAL™ offers fast AST results to effectively and efficiently manage bloodstream infections.

VIDAS^® KUBE™

VIDAS^® KUBE™ is designed to preserve everything labs appreciate about the VIDAS^® Solution combined with advanced technology. VIDAS^® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence.

BIOFIRE^® FILMARRAY^® TORCH

Syndromic infectious disease testing with BIOFIRE^® FILMARRAY^® TORCH is the fastest way to better results.

VITEK^® MS PRIME

VITEK^® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care.

BIOFIRE^® SPOTFIRE^® System

The BIOFIRE^® SPOTFIRE^® System is the latest advancement in molecular infectious disease diagnostics from bioMérieux for Point-of-Care testing, offering rapid and actionable results onsite.

BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat Panels

The BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panels enable testing for respiratory pathogens from either a nasopharyngeal swab or a throat swab, providing a flexible respiratory solution to meet the unique needs of point-of-care settings.

Respiratory Tract Infections

When a patient is suffering from respiratory symptoms, it’s challenging to know what’s causing the illness without diagnostic results. Our respiratory solutions provide fast, comprehensive, and accurate answers for optimized patient care and to fight AMR.

GENE-UP^®

Our real-time PCR solution simplifies workflows, decreases cross-contamination risks, and gives you rapid results that speed up critical manufacturing decisions.

GENE-UP^® TYPER

Move from test results to actionable insights and make impactful decisions within 2 hours from an isolated colony with GENE UP® TYPER. This real-time PCR assay utilizes probabilistic typing of specific microorganisms to help identify the root cause of contamination and avoid future recurrence.

VIDAS^® KUBE™ Automated Food Pathogens Detection

VIDAS® KUBE™’s adaptable automation helps your lab to be more productive, more accurate, and at the forefront of innovation—all-in-one simplifed platform.

TEMPO^® Quality Indicator Solution

TEMPO® is a fully automated enumeration system that tests quality indicators in food products and environmental samples within your laboratory.

ENDONEXT^™Solutions

ENDONEXT™ endotoxin detection assays are ushering in a new era of smarter, more sustainable pharmaceutical quality control.

BIOFIRE^® Mycoplasma

BIOFIRE® Mycoplasma provides simple, accurate, and rapid in-house mycoplasma detection for use in testing raw materials, in-process samples, and final product release. We offer validation services designed to meet regulatory requirements—from documentation to comprehensive on-site support.

3P^® ENTERPRISE

Bridging the gap between standard processes and automation, 3P® ENTERPRISE transforms the future of environmental monitoring in the pharmaceutical industry. From sampling to trending, take control with an end-to-end, fully digitalized and automated workflow. Increase efficiency and ensure your products are safe and compliant with an innovative environmental monitoring system

VITEK^®MS PRIME

The VITEK® MS PRIME is the next level of automated MALDI-TOF Mass Spectrometry system, that allows an accurate identification to the species-level.

Planting a family tree. Hands of grandfather and little boy planting young tree in the garden. Environmental awareness. Spring concept, save nature and care.

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

This dedication to public health is the thread that connects everything we do. It connects us to our history - since 1963, we have been fulfilling the vision of the Mérieux family to improve health, while maintaining the values of respect, accountability, transparency, and sharing. 

Discover more

Shaping the future together in 2025

News

bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance

bioMérieux – 2024 Financial Results

Lab Innovations Empower Clinicians in the Fight Against Antimicrobial Resistance

bioMérieux and Vall d'Hebron Join Forces Against Infectious Diseases

Enabling Decision-Making

As an antimicrobial steward

BE A GAME CHANGER

In the fight against sepsis

BE A GAME CHANGER

As a protector of consumer health

BE A GAME CHANGER

In ensuring quality pharmaceutical goods

BE A GAME CHANGER

In respiratory infections, including COVID-19

BE A GAME CHANGER

VITEK^® REVEAL™

VIDAS^® KUBE™

BIOFIRE^® FILMARRAY^® TORCH

VITEK^® MS PRIME

BIOFIRE^® SPOTFIRE^® System

BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat Panels

Respiratory Tract Infections

GENE-UP^®

GENE-UP^® TYPER

VIDAS^® KUBE™ Automated Food Pathogens Detection

TEMPO^® Quality Indicator Solution

ENDONEXT^™Solutions

BIOFIRE^® Mycoplasma

3P^® ENTERPRISE

VITEK^®MS PRIME

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

PIONEERING DIAGNOSTICS

Company

Other Websites

FOLLOW US ON SOCIAL MEDIA

Shaping the future together in 2025

News

bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance

bioMérieux – 2024 Financial Results

Lab Innovations Empower Clinicians in the Fight Against Antimicrobial Resistance

bioMérieux and Vall d'Hebron Join Forces Against Infectious Diseases

Enabling Decision-Making

As an antimicrobial steward

BE A GAME CHANGER

VITEK® REVEAL™

VIDAS® KUBE™

BIOFIRE® FILMARRAY® TORCH

VITEK® MS PRIME

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

PIONEERING DIAGNOSTICS

Company

Other Websites

FOLLOW US ON SOCIAL MEDIA

VITEK^® REVEAL™

VIDAS^® KUBE™

BIOFIRE^® FILMARRAY^® TORCH

VITEK^® MS PRIME